Blair William & CO Novartis Ag Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Novartis Ag stock. As of the latest transaction made, Blair William & CO holds 80,819 shares of NVS stock, worth $7.95 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

80,819

Previous 81,162 0.42%

Holding current value

$7.95 Million

Previous $8.64 Million 7.58%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $36,402 - $41,465	-343 Reduced 0.42%	80,819 $9.3 Million
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $76,185 - $88,365	-823 Reduced 1.0%	81,162 $8.64 Million
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $311,151 - $354,263	-3,266 Reduced 3.83%	81,985 $7.93 Million
Q4 2023 Feb 12, 2024	BUY	$92.27 - $101.54 $51,671 - $56,862	560 Added 0.66%	85,251 $8.61 Million
Q3 2023 Nov 09, 2023	SELL	$94.73 - $105.13 $217,121 - $240,957	-2,292 Reduced 2.63%	84,691 $8.63 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $164,778 - $186,844	-1,781 Reduced 2.01%	86,983 $8.78 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $156,538 - $181,536	-1,956 Reduced 2.16%	88,764 $8.17 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $614,221 - $752,187	-8,130 Reduced 8.22%	90,720 $8.23 Million
Q3 2022 Nov 09, 2022	SELL	$74.61 - $87.26 $7,461 - $8,726	-100 Reduced 0.1%	98,850 $7.51 Million
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $97,831 - $113,906	-1,215 Reduced 1.21%	98,950 $8.36 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $70,817 - $80,108	-884 Reduced 0.87%	100,165 $8.79 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $821,228 - $908,091	10,304 Added 11.35%	101,049 $8.84 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $388,945 - $452,485	-4,756 Reduced 4.98%	90,745 $7.42 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $2.94 Million - $3.25 Million	-34,468 Reduced 26.52%	95,501 $8.71 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $1.96 Million - $2.31 Million	-23,444 Reduced 15.28%	129,969 $11.1 Million
Q4 2020 Feb 09, 2021	SELL	$78.07 - $94.43 $4.39 Million - $5.31 Million	-56,204 Reduced 26.81%	153,413 $14.5 Million
Q3 2020 Nov 06, 2020	BUY	$82.14 - $91.0 $1.07 Million - $1.19 Million	13,065 Added 6.65%	209,617 $18.2 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $1.04 Million - $1.17 Million	-12,893 Reduced 6.16%	196,552 $17.2 Million
Q1 2020 May 11, 2020	SELL	$70.67 - $99.01 $581,896 - $815,248	-8,234 Reduced 3.78%	209,445 $17.3 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $3.61 Million - $4.08 Million	42,785 Added 24.46%	217,679 $20.6 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $906,296 - $998,684	-10,595 Reduced 5.71%	174,894 $15.2 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $418,319 - $514,854	5,548 Added 3.08%	185,489 $16.9 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $148,079 - $169,370	1,966 Added 1.1%	179,941 $17.3 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $235,491 - $262,217	3,197 Added 1.83%	177,975 $15.3 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $97,933 - $113,280	1,463 Added 0.84%	174,778 $15.1 Million
Q2 2018 Aug 13, 2018	SELL	$64.91 - $73.36 $437,817 - $494,813	-6,745 Reduced 3.75%	173,315 $13.1 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $7.72 Million - $9.23 Million	-109,728 Reduced 37.86%	180,060 $14.6 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $7.76 Million - $8.33 Million	107,267 Added 58.77%	289,788 $24.3 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $13.5 Million - $14.1 Million	182,521	182,521 $15.7 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account